|The IgG n/a (Catalog #MBS830309) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Mouse anti Human IgG antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Mouse anti Human IgG antibody can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB).
WB: 1:500-1:2000. Researchers should empirically determine the suitability of the IgG n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Mouse anti Human IgG antibody with the following immunoassay(s):
Western Blot (Western Blot analysis using Mouse anti Human IgG antibody
Western Blot showing IgG antibody (lane 1, 2) and Albumin antibody (lane 3, 4) used against human serum (lane 1, 3) and plasma (lane 2, 4).)
Mouse monoclonal human IgG antibody.
Biological Significance: Immunoglobulin G (IgG) are antibody molecules. Each IgG is composed of four peptide chains - two heavy chains and two light chains. Each IgG has two antigen binding sites. Other Immunoglobulins may be described in terms of polymers with the IgG structure considered the monomer. Immunogen: Mouse anti Human IgG antibody was raised in Mouse using Human IgG was isolated from human sera and purified by chromatography as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing IgG are readily searchable from our website. Different antibodies against the same target such as IgG may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.